Cargando…

Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Interobserver Agreement on NCCN Resectability Status Criteria

OBJECTIVES: To determine the reproducibility of the National Comprehensive Cancer Network (NCCN) resectability status classification for pancreatic cancer. BACKGROUND: The NCCN classification defines 3 resectability classes (resectable, borderline resectable, locally advanced), according to vascular...

Descripción completa

Detalles Bibliográficos
Autores principales: Giannone, Fabio, Capretti, Giovanni, Abu Hilal, Mohammed, Boggi, Ugo, Campra, Donata, Cappelli, Carla, Casadei, Riccardo, De Luca, Raffaele, Falconi, Massimo, Giannotti, Gabriele, Gianotti, Luca, Girelli, Roberto, Gollini, Paola, Ippolito, Davide, Limerutti, Giorgio, Maganuco, Lorenzo, Malagnino, Valeria, Malleo, Giuseppe, Morone, Mario, Mosconi, Cristina, Mrakic, Federica, Palumbo, Diego, Salvia, Roberto, Sgroi, Salvatore, Zerbi, Alessandro, Balzano, Gianpaolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455302/
https://www.ncbi.nlm.nih.gov/pubmed/37635813
http://dx.doi.org/10.1097/AS9.0000000000000087
_version_ 1785096419561963520
author Giannone, Fabio
Capretti, Giovanni
Abu Hilal, Mohammed
Boggi, Ugo
Campra, Donata
Cappelli, Carla
Casadei, Riccardo
De Luca, Raffaele
Falconi, Massimo
Giannotti, Gabriele
Gianotti, Luca
Girelli, Roberto
Gollini, Paola
Ippolito, Davide
Limerutti, Giorgio
Maganuco, Lorenzo
Malagnino, Valeria
Malleo, Giuseppe
Morone, Mario
Mosconi, Cristina
Mrakic, Federica
Palumbo, Diego
Salvia, Roberto
Sgroi, Salvatore
Zerbi, Alessandro
Balzano, Gianpaolo
author_facet Giannone, Fabio
Capretti, Giovanni
Abu Hilal, Mohammed
Boggi, Ugo
Campra, Donata
Cappelli, Carla
Casadei, Riccardo
De Luca, Raffaele
Falconi, Massimo
Giannotti, Gabriele
Gianotti, Luca
Girelli, Roberto
Gollini, Paola
Ippolito, Davide
Limerutti, Giorgio
Maganuco, Lorenzo
Malagnino, Valeria
Malleo, Giuseppe
Morone, Mario
Mosconi, Cristina
Mrakic, Federica
Palumbo, Diego
Salvia, Roberto
Sgroi, Salvatore
Zerbi, Alessandro
Balzano, Gianpaolo
author_sort Giannone, Fabio
collection PubMed
description OBJECTIVES: To determine the reproducibility of the National Comprehensive Cancer Network (NCCN) resectability status classification for pancreatic cancer. BACKGROUND: The NCCN classification defines 3 resectability classes (resectable, borderline resectable, locally advanced), according to vascular invasion. It is used to recommend different approaches and stratify patients during clinical trials. METHODS: Prospective, multicenter, observational study (trial ID: NCT03673423). Main outcome measure was the interobserver agreement of tumor assignment to different resectability classes and quantification of vascular invasion degrees. Agreement was measured by Fleiss’ k (k = 1 perfect agreement; k = 0 agreement by chance). Sixty-nine computed tomography (CT) scans of pathologically confirmed pancreatic adenocarcinoma were independently reviewed in a blinded fashion by 22 observers from 11 hospitals (11 surgeons and 11 radiologists). Rating differences between surgeons or radiologists and between hospitals with different volumes (≥60 or <60 resections/year) were assessed. RESULTS: Complete agreement among 22 observers was recorded in 5 CT scans (7.2%), whereas 25 CT scans (36.2%) were variously assigned to all 3 resectability classes. Interobserver agreement varied from fair to moderate (Fleiss’ k range: 0.282–0.555), with the lowest agreement for borderline resectable tumors. Assessing vascular contact ≤180° had the lowest agreement for all vessels (k range: 0.196–0.362). The highest concordance was recorded for venous invasion >180° (k range: 0.619–0.756). Neither reviewers’ specialty nor hospital volume influenced the agreement. CONCLUSIONS: There is high variability in the assignment to resectability categories, which may compromise the reliability of treatments recommendations and the evidence of trials stratifying patients in resectability classes. Criteria should be revised to allow a reproducible classification.
format Online
Article
Text
id pubmed-10455302
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer Health, Inc.
record_format MEDLINE/PubMed
spelling pubmed-104553022023-08-26 Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Interobserver Agreement on NCCN Resectability Status Criteria Giannone, Fabio Capretti, Giovanni Abu Hilal, Mohammed Boggi, Ugo Campra, Donata Cappelli, Carla Casadei, Riccardo De Luca, Raffaele Falconi, Massimo Giannotti, Gabriele Gianotti, Luca Girelli, Roberto Gollini, Paola Ippolito, Davide Limerutti, Giorgio Maganuco, Lorenzo Malagnino, Valeria Malleo, Giuseppe Morone, Mario Mosconi, Cristina Mrakic, Federica Palumbo, Diego Salvia, Roberto Sgroi, Salvatore Zerbi, Alessandro Balzano, Gianpaolo Ann Surg Open Original Study OBJECTIVES: To determine the reproducibility of the National Comprehensive Cancer Network (NCCN) resectability status classification for pancreatic cancer. BACKGROUND: The NCCN classification defines 3 resectability classes (resectable, borderline resectable, locally advanced), according to vascular invasion. It is used to recommend different approaches and stratify patients during clinical trials. METHODS: Prospective, multicenter, observational study (trial ID: NCT03673423). Main outcome measure was the interobserver agreement of tumor assignment to different resectability classes and quantification of vascular invasion degrees. Agreement was measured by Fleiss’ k (k = 1 perfect agreement; k = 0 agreement by chance). Sixty-nine computed tomography (CT) scans of pathologically confirmed pancreatic adenocarcinoma were independently reviewed in a blinded fashion by 22 observers from 11 hospitals (11 surgeons and 11 radiologists). Rating differences between surgeons or radiologists and between hospitals with different volumes (≥60 or <60 resections/year) were assessed. RESULTS: Complete agreement among 22 observers was recorded in 5 CT scans (7.2%), whereas 25 CT scans (36.2%) were variously assigned to all 3 resectability classes. Interobserver agreement varied from fair to moderate (Fleiss’ k range: 0.282–0.555), with the lowest agreement for borderline resectable tumors. Assessing vascular contact ≤180° had the lowest agreement for all vessels (k range: 0.196–0.362). The highest concordance was recorded for venous invasion >180° (k range: 0.619–0.756). Neither reviewers’ specialty nor hospital volume influenced the agreement. CONCLUSIONS: There is high variability in the assignment to resectability categories, which may compromise the reliability of treatments recommendations and the evidence of trials stratifying patients in resectability classes. Criteria should be revised to allow a reproducible classification. Wolters Kluwer Health, Inc. 2021-08-11 /pmc/articles/PMC10455302/ /pubmed/37635813 http://dx.doi.org/10.1097/AS9.0000000000000087 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Study
Giannone, Fabio
Capretti, Giovanni
Abu Hilal, Mohammed
Boggi, Ugo
Campra, Donata
Cappelli, Carla
Casadei, Riccardo
De Luca, Raffaele
Falconi, Massimo
Giannotti, Gabriele
Gianotti, Luca
Girelli, Roberto
Gollini, Paola
Ippolito, Davide
Limerutti, Giorgio
Maganuco, Lorenzo
Malagnino, Valeria
Malleo, Giuseppe
Morone, Mario
Mosconi, Cristina
Mrakic, Federica
Palumbo, Diego
Salvia, Roberto
Sgroi, Salvatore
Zerbi, Alessandro
Balzano, Gianpaolo
Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Interobserver Agreement on NCCN Resectability Status Criteria
title Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Interobserver Agreement on NCCN Resectability Status Criteria
title_full Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Interobserver Agreement on NCCN Resectability Status Criteria
title_fullStr Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Interobserver Agreement on NCCN Resectability Status Criteria
title_full_unstemmed Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Interobserver Agreement on NCCN Resectability Status Criteria
title_short Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Interobserver Agreement on NCCN Resectability Status Criteria
title_sort resectability of pancreatic cancer is in the eye of the observer: a multicenter, blinded, prospective assessment of interobserver agreement on nccn resectability status criteria
topic Original Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455302/
https://www.ncbi.nlm.nih.gov/pubmed/37635813
http://dx.doi.org/10.1097/AS9.0000000000000087
work_keys_str_mv AT giannonefabio resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria
AT caprettigiovanni resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria
AT abuhilalmohammed resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria
AT boggiugo resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria
AT campradonata resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria
AT cappellicarla resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria
AT casadeiriccardo resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria
AT delucaraffaele resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria
AT falconimassimo resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria
AT giannottigabriele resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria
AT gianottiluca resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria
AT girelliroberto resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria
AT gollinipaola resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria
AT ippolitodavide resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria
AT limeruttigiorgio resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria
AT maganucolorenzo resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria
AT malagninovaleria resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria
AT malleogiuseppe resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria
AT moronemario resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria
AT mosconicristina resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria
AT mrakicfederica resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria
AT palumbodiego resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria
AT salviaroberto resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria
AT sgroisalvatore resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria
AT zerbialessandro resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria
AT balzanogianpaolo resectabilityofpancreaticcancerisintheeyeoftheobserveramulticenterblindedprospectiveassessmentofinterobserveragreementonnccnresectabilitystatuscriteria